Blood sugar levels and recovery in intensive care
Part of Hormones & metabolism, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study looks at whether a simple blood test ratio can help predict how well critically ill patients do in the intensive care unit (ICU). It aims to understand if stress-related high blood sugar affects recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You need to be in the intensive care unit (ICU) and expected to stay there for a while.
- You must have a blood sugar test and a long-term blood sugar test (HbA1c) done early in your ICU stay.
- You or your family must agree to join the study.
- You cannot join if you have certain urgent diabetes emergencies, like diabetic ketoacidosis or hyperosmolar hyperglycemic state.
- You cannot join if you recently had a blood transfusion or have a blood disorder that affects the HbA1c test.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing two ways of monitoring blood sugar in intensive care patients: continuous monitoring (a sensor) versus intermittent checks. If you are in the ICU with high blood sugar and on IV insulin, this study might help find a better way to manage your levels.
This study is testing how immune cells use sugar (glucose) in people who are in the intensive care unit (ICU). By doing this test, researchers hope to learn more about how the body fights illness during critical care, which could lead to better treatments.
This study compares two types of blood tests (from a vein and an artery) to see if they give similar information about oxygen and carbon dioxide levels in critically ill patients, especially those with diabetes. The results may help doctors choose the best way to monitor patients in the ICU.
This study looks at how well continuous glucose monitors (small sensors under the skin that track sugar levels) work in ICU patients who need insulin. If you are in the ICU, on insulin, and already have a sensor, you may be able to join.
This trial checks whether a continuous glucose monitoring system (“CGM GUARDIAN 2”) can be used safely and effectively for people in the ICU who have septic shock and high blood sugar. It may help the medical team track blood sugar more easily while you receive insulin.
This study measures a specific blood protein (carbohydrate-deficient transferrin) when patients arrive at the hospital to see if it can predict how well they'll do in the intensive care unit. Understanding this marker might help doctors better plan care for critically ill patients.
Hear when a new Critical Illness trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.